Skip to main content
. Author manuscript; available in PMC: 2020 Nov 14.
Published in final edited form as: Med Decis Making. 2020 Oct 20;40(8):1034–1040. doi: 10.1177/0272989X20961095

Table 1:

UKFSS Trial estimated and model-predicted hazard ratios, and 17-year CRC incidence and mortality per 100,000 persons screened based on per protocol analysis. All estimates are expressed with a point estimate and 95% credible or confidence intervals.

Outcome Source Hazard Ratio 17-year rate control group 17-year rate screened group
Incidence (All-site)
CRC-SPIN2.0 .56 (.51, .61) 200 (193, 207) 114 (105, 123)
MISCAN .61 (.57, .66) 231 (223, 238) 144 (134, 154)
SimCRC .66 (.61, .72) 212 (204, 219) 143 (122, 153)
UKFSS .65 (.59, .71) 184 (178, 191) 120 (112, 128)
Incidence (Distal)
CRC-SPIN2.0 .33 (.28, .38) 99 (94, 104) 32 (28, 37)
MISCAN .59 (.53, .65) 117 (112, 123) 69 (62, 75)
SimCRC .53 (.48, .58) 144 (138, 150) 76 (69, 82)
UKFSS .44 (.38, .50) 112 (107, 117) 50 (45, 56)
Incidence (Proximal)
CRC-SPIN2.0 .81 (.73, .90) 101 (96, 105) 82 (74, 89)
MISCAN .67 (.60,.74) 113 (108, 118) 75 (68, 82)
SimCRC .99 (.88,1.12) 68 (64, 72) 67 (61, 74)
UKFSS .95 (.83, 1.09) 71 (67, 75) 66 (60, 73)
Mortality
CRC-SPIN2.0 .47 (.40, .54) 70 (66, 74) 33 (29, 38)
MISCAN .49 (.41, .57) 54 (50, 57) 26 (22, 30)
SimCRC .60 (.52, .69) 73 (69, 77) 44 (39, 49)
UKFSS .59 (.49, .70) 56 (53, 59) 33 (29, 38)